Showing results (51-60 of 98) with videos related to
Sort By:
Pageof 10
Journal of Bone Oncology|February 25, 2016
Bone-targeted agent use for bone metastases from breast cancer and prostate cancer: A patient surveyBrian Hutton, Patricia Morretto, Urban Emmenegger, et al.Cureus|April 16, 2016
Avascular Necrosis of the Femoral Head After Palliative Radiotherapy in Metastatic Prostate Cancer: Absence of a Dose Threshold?Alia M Daoud, Mack Hudson, Kenneth G Magnus, et al.Cancer Research|April 6, 2006
Targeted anti-vascular endothelial growth factor receptor-2 therapy leads to short-term and long-term impairment of vascular function and increase in tumor hypoxiaMarcela Franco, Shan Man, Limor Chen, et al.Molecular Cancer Therapeutics|October 15, 2008
Long-term progression and therapeutic response of visceral metastatic disease non-invasively monitored in mouse urine using beta-human choriogonadotropin secreting tumor cell linesGiulio Francia, Urban Emmenegger, Christina R Lee, et al.Cancer Research|September 22, 2016
Efficacy of Cotargeting Angiopoietin-2 and the VEGF Pathway in the Adjuvant Postsurgical Setting for Early Breast, Colorectal, and Renal CancersFlorence T H Wu, Shan Man, Ping Xu, et al.European Journal of Pharmacology|August 22, 2009
Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancerAnna Fioravanti, Bastianina Canu, Greta Alì, et al.BJU International|February 9, 2012
Phase II study of cytarabine in men with docetaxel-refractory, castration-resistant prostate cancer with evaluation of TMPRSS2-ERG and SPINK1 as serum biomarkersNeesha C Dhani, Urban Emmenegger, Laurie Adams, et al.Cancer|April 2, 2021
Examining the ability of the Cancer and Aging Research Group tool to predict toxicity in older men receiving chemotherapy or androgen-receptor-targeted therapy for metastatic castration-resistant prostate cancerShabbir M H Alibhai, Henriette Breunis, Aaron R Hansen, et al.European Urology Focus|January 16, 2019
What Is Oligometastatic Prostate Cancer?Michael Fraser, Bridget Koontz, Urban Emmenegger, et al.Clinical Genitourinary Cancer|February 27, 2023
Sarcopenia in Men With Bone-Predominant Metastatic Castration-Resistant Prostate Cancer Undergoing Ra-223 TherapyMaira Khan, Shruti Parshad, Mahdi F Naimi, et al.Pageof 10